- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.76 Å
- Oligo State
- monomer
- Ligands
- 15 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- 1 x I0L: (4R)-4-[(2E)-4,4-diethyl-2-imino-6-oxo-1,3-diazinan-1-yl]-N-[(4S)-2,2-dimethyl-3,4-dihydro-2H-1-benzopyran-4-yl]-3,4-dihydro-2H-1-benzopyran-6-carboxamide(Non-covalent)
I0L.18: 19 residues within 4Å:- Chain A: S.35, Q.36, I.53, D.55, G.57, S.58, F.100, S.102, F.144, I.147, F.149, I.152, D.246, G.248, S.250, I.317, L.328
- Ligands: EDO.1, EDO.11
14 PLIP interactions:14 interactions with chain A- Hydrophobic interactions: A:Q.36, A:I.53, A:F.100, A:F.100, A:F.144, A:I.147, A:F.149, A:I.152, A:L.328
- Hydrogen bonds: A:S.58, A:S.102, A:G.248
- Salt bridges: A:D.55, A:D.246
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hodder, A.N. et al., Basis for drug selectivity of plasmepsin IX and X inhibition in Plasmodium falciparum and vivax. Structure (2022)
- Release Date
- 2022-05-04
- Peptides
- Plasmepsin 10: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.76 Å
- Oligo State
- monomer
- Ligands
- 15 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- 1 x I0L: (4R)-4-[(2E)-4,4-diethyl-2-imino-6-oxo-1,3-diazinan-1-yl]-N-[(4S)-2,2-dimethyl-3,4-dihydro-2H-1-benzopyran-4-yl]-3,4-dihydro-2H-1-benzopyran-6-carboxamide(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hodder, A.N. et al., Basis for drug selectivity of plasmepsin IX and X inhibition in Plasmodium falciparum and vivax. Structure (2022)
- Release Date
- 2022-05-04
- Peptides
- Plasmepsin 10: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A